Senior Director, US Liver, COVID-19 and Emerging Therapies Forecasting

at Gilead Sciences, Inc.
Published September 19, 2022
Location Foster City, CA
Category Default  
Job Type Full-time  


For Current Gilead Employees and Contractors:

Please log onto your Internal Career Site to apply for this job.

Job Description

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

We have the following opportunity based in our Foster City, CA location:

Senior Director, US Liver, COVID-19 and Emerging Therapies Forecasting

The Senior Director of US Liver, COVID-19 and Emerging Therapies Forecasting will be responsible for leading forecasting for Gilead's US inline and launch products in the 0 - 2 year window across Gilead's US Liver, COVID-19 and Mature Products portfolio. The role will also lead Capabilities Hub for the Forecasting function across all business units, and be responsible for new Emerging Therapeutic Areas. This role will manage a team of ~3 people and report to the Executive Director of US Liver, COVID-19, Emerging Therapies and Capabilities Hub Integrated Insights. This role requires leveraging a broad and deep skill set (functional expertise, therapeutic area knowledge, communication skills, leadership and influencing, executive presence, etc.) to help drive the success of work across a variety of key stakeholders - including business unit, brand and managed markets marketing leads, peer functional leads within Commercial Operations, Finance, Manufacturing, and executive leadership.

Specific Responsibilities:

* Lead a ~3 person team responsible for forecasting across the Liver, COVID-19, Cardiopulmonary (CP) and Emerging products business

* Lead and deliver Gilead's quarterly Latest Estimate (LE) forecasting for US Liver, COVID-19, and CP inline and launch products, including developing forecast scenario analyses, highlighting key risks and opportunities to clearly characterize forecast uncertainties and key drivers for executive leadership

* Developing forecast scenario analyses including key risks and opportunities to clearly characterize forecast uncertainties and key drivers for executive leadership

* Support the preparation of the quarterly CCO Binder and earnings deliverables for Liver, COVID-19 and Mature Products with the Executive Director

* Analyze secondary data sources (script data like IMS, audit data like Ipsos, epidemiology data like NHANES, claims data, etc.) to glean insights and understand implications for our business, inform our strategies, and make actionable recommendations.

* Collaborate within Commercial Operations on key forecast inputs including market research, analytics, and sales analytics/field-force assumptions

* Regularly communicate with senior executives and strategic partners to report analytical findings and projections related to forecasting, inventory management, and key performance metrics/diagnostics

* Lead performance reporting and diagnostics, including design and implementation of HQ facing dashboards and reports

* Lead Forecasting Capabilities Hub to share functional expertise and innovation ideas across all TA teams

* Seek opportunities to streamline and improve business operations and technical capabilities of the organization, while identifying opportunities to innovate to drive performance

Knowledge, Experience & Skills

* Minimum of 12-14 years' experience in the Pharmaceutical, Biotech or related industry experience dependent on experience and education level. BS degree (or higher) in life sciences or medicine (or equivalent); Advanced degrees desirable

* A foundation of experience in one or more of Gilead's key therapeutic areas that this function is responsible for (Liver, COVID-19, CP, or emerging therapy area) is preferred

* Evidence of team and project leadership (interaction with cross-functional partners, conflict resolution, and consensus-driving) and project management (planning, prioritization, objective setting, meeting management, and plan execution) is required

* Prior experience building a team, defining new roles, and driving successful implementation is highly desired

* Persuasive written and verbal communication skills, ability to lead, influence, resolve conflict and drive consensus among diverse cross functional stakeholders.

* Strong prior experience in biotech/pharma revenue forecasting is preferred

* Proven experience communicating complicated analytics simply and clearly for senior management is required

* Deep understanding of biotech/pharma market trends, best practices to enable forward looking plans

* Proven history of working and delivering on multiple projects simultaneously, with tight deadlines and changing priorities is required

* Strong ability to use Microsoft Office (specifically PowerPoint and Excel) to present quantitative data in graphical form is required

* Passionate about the function

Basic Qualifications:

High School Degree and Eighteen Years' Experience


Associates Degree and Sixteen Years' Experience


Bachelor's Degree and Fourteen Years' Experience


Masters' Degree and Twelve Years' Experience


PhD and Twelve Years' Experience

For jobs in the United States:

As an equal opportunity employer, Gilead Sciences Inc. is committed to a diverse workforce. Employment decisions regarding recruitment and selection will be made without discrimination based on race, color, religion, national origin, gender, age, sexual orientation, physical or mental disability, genetic information or characteristic, gender identity and expression, veteran status, or other non-job related characteristics or other prohibited grounds specified in applicable federal, state and local laws. In order to ensure reasonable accommodation for individuals protected by Section 503 of the Rehabilitation Act of 1973, the Vietnam Era Veterans' Readjustment Act of 1974, and Title I of the Americans with Disabilities Act of 1990, applicants who require accommodation in the job application process may contact [Click Here to Email Your Resumé] for assistance.

Following extensive monitoring, research, consideration of business implications and advice from internal and external experts, Gilead has made the decision to require all U.S., Canada, Australia, Singapore, and Hong Kong employees and contractors to receive the COVID-19 vaccines as a condition of employment. "Full vaccination" is defined as two weeks after both doses of a two-dose vaccine or two weeks since a single-dose vaccine has been administered. Anyone unable to be vaccinated, either because of a sincerely held religious belief or a medical condition or disability that prevents them from being vaccinated, can request a reasonable accommodation.

For more information about equal employment opportunity protections, please view the 'EEO is the Law' poster.




Our environment respects individual differences and recognizes each employee as an integral member of our company. Our workforce reflects these values and celebrates the individuals who make up our growing team.

Gilead provides a work environment free of harassment and prohibited conduct. We promote and support individual differences and diversity of thoughts and opinion.

For Current Gilead Employees and Contractors:

Please log onto your Internal Career Site to apply for this job.

Drop files here browse files ...